يعرض 1 - 10 نتائج من 40 نتيجة بحث عن '"Lynn Jongen"', وقت الاستعلام: 1.94s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris

    المؤلفون: Laurence Slembrouck, Lauren Darrigues, Cecile Laurent, Lorenza Mittempergher, Leonie JMJ Delahaye, Isabelle Vanden Bempt, Sara Vander Borght, Liesbet Vliegen, Petra Sintubin, Virginie Raynal, Mylene Bohec, Cécile Reyes, Audrey Rapinat, Céline Helsmoortel, Lynn Jongen, Griet Hoste, Patrick Neven, Hans Wildiers, Ann Smeets, Ines Nevelsteen, Kevin Punie, Els Van Nieuwenhuysen, Sileny Han, Anne Vincent Salomon, Enora Laas Faron, Timothé Cynober, David Gentien, Sylvain Baulande, Mireille HJ Snel, Anke T Witteveen, Sari Neijenhuis, Annuska M Glas, Fabien Reyal, Giuseppe Floris

    المصدر: Translational Oncology, Vol 12, Iss 12, Pp 1557-1565 (2019)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: http://www.sciencedirect.com/science/article/pii/S1936523319303511; https://doaj.org/toc/1936-5233

    URL الوصول: https://doaj.org/article/7dd90bdd8d2b401cbc180de9d3769d13

    View record from ScienceDirect Full Text via ClinicalKey Full Text Finder
    أضف إلى المفضلة
  2. 2
    Figure S4 from Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial

    المؤلفون: Henk-Jan Guchelaar, Ben Van Calster, Vincent Olaf Dezentjé, Ignace Vergote, Robert Paridaens, Johan Van Ginderachter, Willem Lybaert, Sabine Van Huffel, Minne Casteels, Wim Wynendaele, Peter Vuylsteke, Markus Joerger, Didier Verhoeven, Patrick Berteloot, Jan Decloedt, Olivier Brouckaert, Anne-Sophie Dieudonné, Hans Wildiers, An Poppe, Diether Lambrechts, Chantal Blomme, Kathleen Van Asten, Anneleen Lintermans, Lynn Jongen, Patrick Neven

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11fdb0600a05e7a84478d0598a6582ef
    https://doi.org/10.1158/1078-0432.22464215

    أضف إلى المفضلة
  3. 3
    Table S1 from Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial

    المؤلفون: Henk-Jan Guchelaar, Ben Van Calster, Vincent Olaf Dezentjé, Ignace Vergote, Robert Paridaens, Johan Van Ginderachter, Willem Lybaert, Sabine Van Huffel, Minne Casteels, Wim Wynendaele, Peter Vuylsteke, Markus Joerger, Didier Verhoeven, Patrick Berteloot, Jan Decloedt, Olivier Brouckaert, Anne-Sophie Dieudonné, Hans Wildiers, An Poppe, Diether Lambrechts, Chantal Blomme, Kathleen Van Asten, Anneleen Lintermans, Lynn Jongen, Patrick Neven

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::005fbe1f518021fc5cec158a2b790adf
    https://doi.org/10.1158/1078-0432.22464209.v1

    أضف إلى المفضلة
  4. 4
    Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2− early breast cancer

    المؤلفون: Ines Nevelsteen, Ann Smeets, Chantal Van Ongeval, Hans Wildiers, Anne-Sophie Van Rompuy, Laurence Slembrouck, Caroline Weltens, G Hoste, Els Van Nieuwenhuysen, Giuseppe Floris, Isabelle Vanden Bempt, Kevin Punie, Patrick Neven, Lynn Jongen, Sileny Han

    المصدر: Modern Pathology. 34:1297-1309

    مصطلحات موضوعية: Adult, 0301 basic medicine, Oncology, Pathology, medicine.medical_specialty, Receptor, ErbB-2, Adjuvant chemotherapy, Concordance, Estrogen receptor, Breast Neoplasms, Pathology and Forensic Medicine, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Biomarkers, Tumor, medicine, Humans, In patient, Aged, Retrospective Studies, Early breast cancer, Models, Statistical, Framingham Risk Score, Breast cancer recurrence, business.industry, Middle Aged, University hospital, 030104 developmental biology, Receptors, Estrogen, 030220 oncology & carcinogenesis, Female, Transcriptome, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::029f117e5edbb3070e6dca02e8b0ba8b
    https://doi.org/10.1038/s41379-021-00743-8

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest
    أضف إلى المفضلة
  5. 5
    Abstract P3-07-14: Multigene signatures based risk estimates in early ER+/HER2- breast cancer: The predictive value of inexpensive statistical models and changes in adjuvant chemotherapy use

    المؤلفون: Sileny Han, Erik Van Limbergen, Ines Nevelsteen, Ann Smeets, Lynn Jongen, Hans Wildiers, Isabelle Vanden Bempt, Giuseppe Floris, Philippe Moerman, Laurence Slembrouck, Patrick Neven, Kevin Punie, Caroline Weltens, G Hoste, Els Van Nieuwenhuysen

    المصدر: Cancer Research. 80:P3-07

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, business.industry, Adjuvant chemotherapy, medicine.medical_treatment, Concordance, Estrogen receptor, Cancer, Retrospective cohort study, medicine.disease, Predictive value, Breast cancer, Internal medicine, medicine, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7704adc3e02b8a13a69885a5d0931434
    https://doi.org/10.1158/1538-7445.sabcs19-p3-07-14

    أضف إلى المفضلة
  6. 6
    Abstract P1-10-04: Impact of body mass index (BMI) on the predictive and prognostic value of stromal tumor-infiltrating lymphocytes (sTIL) in triple-negative breast cancer (TNBC) patients treated with neoadjuvant chemotherapy (NACT)

    المؤلفون: Francois Richard, Ignace Vergote, Ann Smeets, Hans Wildiers, F Reyal, Christine Desmedt, Giuseppe Floris, Elia Biganzoli, Jan Ardui, Kevin Punie, Didier Meseure, Lynn Jongen, Maricl Lae, Patrick Neven, Anne-Sophie Hamy-Petit, Diane Decroze, Patrick Berteloot

    المصدر: Cancer Research. 80:P1-10

    مصطلحات موضوعية: Oncology, Cancer Research, Chemotherapy, medicine.medical_specialty, business.industry, medicine.medical_treatment, Cancer, Overweight, medicine.disease, Breast cancer, Internal medicine, Medicine, Underweight, medicine.symptom, Stromal tumor, business, Body mass index, Triple-negative breast cancer

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c5999b75599236198197152c11e264dc
    https://doi.org/10.1158/1538-7445.sabcs19-p1-10-04

    أضف إلى المفضلة
  7. 7
    Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris

    المؤلفون: Hans Wildiers, Cécile Reyes, Sileny Han, Lorenza Mittempergher, Timothé Cynober, F Reyal, Leonie J. M. J. Delahaye, Kevin Punie, Liesbet Vliegen, Ines Nevelsteen, Enora Laas Faron, Laurence Slembrouck, Petra Sintubin, Sara Vander Borght, G Hoste, Patrick Neven, Giuseppe Floris, Audrey Rapinat, Ann Smeets, Sylvain Baulande, Lynn Jongen, Mylène Bohec, Virginie Raynal, David Gentien, Céline Helsmoortel, Mireille Snel, Els Van Nieuwenhuysen, Lauren Darrigues, Isabelle Vanden Bempt, Anke T. Witteveen, Sari Neijenhuis, Cecile Laurent, Annuska M. Glas, Anne Vincent Salomon

    المصدر: Translational Oncology, Vol 12, Iss 12, Pp 1557-1565 (2019)
    Translational Oncology

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Original article, Microarray, Concordance, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, MammaPrint, Internal medicine, medicine, medicine.diagnostic_test, business.industry, medicine.disease, University hospital, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Subtyping, 030104 developmental biology, 030220 oncology & carcinogenesis, Gene chip analysis, Risk classification, business

    وصف الملف: Print-Electronic

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6b312847395e353c90474276695b5c1
    http://www.sciencedirect.com/science/article/pii/S1936523319303511

    View record from ScienceDirect Full Text via ClinicalKey
    أضف إلى المفضلة
  8. 8
    Abstract P4-08-25: Decentralized beta testing of MammaPrint and BluePrint NGS kit at University Hospitals Leuven and Curie Institute Paris

    المؤلفون: Leonie J. M. J. Delahaye, Liesbet Vliegen, P Sintubin, Laurence Slembrouck, E Van Nieuwenhuysen, I. Vanden Bempt, C Helsmoortel, L Darrigues, S Vander Borght, EL Faron, Cécile Reyes, Sileny Han, H. Wildiers, Lynn Jongen, G Hoste, Annuska M. Glas, Patrick Neven, S Neijenhuis, V Raynal, L. Mittempergher, Anne Vincent Salomon, A Smeets, K Punie, Guiseppe Floris, Anke T. Witteveen, Mylène Bohec, Timothé Cynober, F Reyal, Ines Nevelsteen, Audrey Rapinat, Cécile Laurent

    المصدر: Cancer Research. 79:P4-08

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, medicine.diagnostic_test, business.industry, Concordance, Cancer, medicine.disease, Beta testing, University hospital, Subtyping, Breast cancer, MammaPrint, Internal medicine, Invasive lobular carcinoma, medicine, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::26884e68e7d8efc70058ac9231827730
    https://doi.org/10.1158/1538-7445.sabcs18-p4-08-25

    أضف إلى المفضلة
  9. 9
    Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

    المؤلفون: Ignace Vergote, Hans Wildiers, F Reyal, Ann Smeets, Marick Laé, Giuseppe Floris, Diane De Croze, Francois Richard, Lynn Jongen, Christine Desmedt, Anne-Sophie Hamy, Elia Biganzoli, Kevin Punie, Didier Meseure, Anne Vincent Salomon, Jan Ardui, Patrick Berteloot, Patrick Neven

    المصدر: J Natl Cancer Inst

    مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Breast Neoplasms, Triple Negative Breast Neoplasms, Overweight, Logistic regression, Gastroenterology, Body Mass Index, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Lymphocytes, Tumor-Infiltrating, Internal medicine, medicine, Humans, Obesity, Triple-negative breast cancer, 030304 developmental biology, 0303 health sciences, business.industry, Hazard ratio, Odds ratio, Articles, medicine.disease, Confidence interval, Oncology, Receptors, Estrogen, 030220 oncology & carcinogenesis, Female, medicine.symptom, business, Body mass index

    وصف الملف: Print

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb6da543f93e5970a8360b1ed06d1b1d
    https://europepmc.org/articles/PMC7850533/

    أضف إلى المفضلة
  10. 10
    Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer

    المؤلفون: Laurence Slembrouck, G Hoste, Johan Menten, Hans Wildiers, Carlos L. Arteaga, Isabelle Vanden Bempt, Giuseppe Floris, Kevin Punie, Tom Matton, Lynn Jongen, Sara Vander Borght, Patrick Neven

    المصدر: Clinical Drug Investigation. 38:1071-1075

    مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Antineoplastic Agents, Hormonal, Class I Phosphatidylinositol 3-Kinases, Receptor, ErbB-2, Breast Neoplasms, UNEXPECTED BENEFIT, 03 medical and health sciences, 0302 clinical medicine, Pharmacotherapy, Breast cancer, Internal medicine, Humans, Medicine, Pharmacology (medical), Fulvestrant, neoplasms, business.industry, HER2 negative, General Medicine, Middle Aged, medicine.disease, Metastatic breast cancer, Thiazoles, 030104 developmental biology, Receptors, Estrogen, 030220 oncology & carcinogenesis, Mutation, Cancer gene, Female, business, Progressive disease, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ca1c7fe215157ad69ca970269549659
    https://doi.org/10.1007/s40261-018-0696-3

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء